Evaluating Life Science Investments: A Guide for Individual Investors
This course helps individual investors evaluate the clinical data and regulatory risks behind biotech investments. Think of this process like performing a diagnostic workup before beginning a complex course of treatment.
Critical Assessment of Clinical Trial Design and Endpoints
Learn how clinical trials are designed and why the metrics used to measure success matter for your investment. Understanding trial protocols is like reviewing a patient's medical history to understand their baseline health before recommending a specific therapy.
Regulatory Strategy and Data Integrity
Understand the drug approval process and why high-quality data is critical for a company's future value. Managing regulatory expectations is like monitoring a patient's recovery to ensure they stay on the right care plan.
Risk Mitigation and Valuation Adjustments
Learn to manage your risk and potential returns by understanding how deals are structured. Structuring an investment is like establishing a tiered treatment plan where follow-up care is based on the patient's progress.